SCM gets grant boost for expansion plans
UK CMO SCM Pharma says a grant from UKTI is a boost for expansion plans and efforts to win clients in key pharmaceutical industry R&D hubs.
Archives for February 10, 2010
GSK R&D cuts to begin in Harlow, say reports
UK drug major GSK will start its programme of R&D cuts at the facility in Harlow, Essex at which it makes pain relief, anxiety and depression drugs.
Almac expands development offering with Xcelodose
Almac Pharma Services has bolstered its product development offering with a new Xcelodose 600s precision powder micro-dosing system that, it claims, can cut processing time, API usage and costs.
US patent for NexBio sialic acid targeting flu drug tech
US biotechnology firm NexBio has received a patent for “pioneering” host cell-targeting influenza drugs that can cut the risk of viral mutation and the emergence of drug resistant strains.
WHO responds to reports of hospitals charging for drugs in Haiti
The WHO has stopped sending free drugs to private hospitals and non-governmental organisations in Haiti after receiving reports that some institutions in the earthquake stricken country had begun to charge patients.
Appointments at GlaxoSmithKline, Synthon, BioSante and Xencor – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at GlaxoSmithKline, Synthon, BioSante and Xencor.
CRO NexMed raises $2.7m to develop delivery tech
CRO NexMed has received a $2.7m (€2.0m) cash boost, which improves its financial situation and provides funds to develop its NexACT technology for oral and transdermal delivery.
SIRO joins with DreamCIS to access Korean patient pool
SIRO Clinpharm has formed an alliance with South Korea-based CRO DreamCIS to expand its clinical trial offering in Asia Pacific and provide clients with more options for patient recruitment.